Cellebrite DI Ltd. (CLBT)

$4.47

-0.22 (-4.69%)
Rating:
Recommendation:
-
Symbol CLBT
Price $4.47
Beta 1.229
Volume Avg. 0.12M
Market Cap 847.731M
Shares () -
52 Week Range 3.8-8.83
1y Target Est -
DCF Unlevered CLBT DCF ->
DCF Levered CLBT LDCF ->
ROE -
ROA -
Operating Margin -
Debt / Equity -
P/E 5.39 Buy
P/B -
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest CLBT news


Technology
Software—Infrastructure
NASDAQ Global Select

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.